UCN-01 and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer
Status:
Completed
Trial end date:
2004-09-01
Target enrollment:
Participant gender:
Summary
RATIONALE: UCN-01 may stop the growth of tumor cells by blocking the enzymes necessary for
tumor cell growth. Drugs used in chemotherapy use different ways to stop tumor cells from
dividing so they stop growing or die. Combining UCN-01 with chemotherapy may kill more tumor
cells.
PURPOSE: Phase II trial to study the effectiveness of combining UCN-01 with fluorouracil in
treating patients who have metastatic pancreatic cancer that has not responded to treatment
with gemcitabine.